Commerce Bank decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 12.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,155 shares of the exchange traded fund’s stock after selling 439 shares during the period. Commerce Bank’s holdings in SPDR S&P Biotech ETF were worth $312,000 as of its most recent SEC filing.
Several other institutional investors also recently added to or reduced their stakes in XBI. Tidemark LLC grew its stake in shares of SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after purchasing an additional 199 shares during the last quarter. ORG Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at approximately $40,000. Quintet Private Bank Europe S.A. purchased a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $40,000. ORG Wealth Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $44,000. Finally, Waldron Private Wealth LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $54,000.
SPDR S&P Biotech ETF Price Performance
SPDR S&P Biotech ETF stock opened at $100.00 on Thursday. SPDR S&P Biotech ETF has a 1-year low of $72.10 and a 1-year high of $105.47. The company has a market cap of $7.62 billion, a PE ratio of 11.47 and a beta of 1.11. The stock’s 50 day moving average price is $98.33 and its 200 day moving average price is $96.46.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- 3 REITs to Buy and Hold for the Long Term
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Evaluate a Stock Before BuyingÂ
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.